MINERVAX
Minervax is pursuing the development of a vaccine against Group B streptococcus (GBS) infections by utilizing a particular fusion protein, which has proved to elicit good protective immunity. A vaccine including this fusion protein will likely elicit protective immunity against many clinically relevant GBS strains.
MINERVAX
Industry:
Biotechnology Health Care Life Science Medical Wellness
Founded:
2010-01-01
Address:
Hellerup, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.minervax.com
Total Employee:
1+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
81.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Mobile Non Scaleable Content Euro Organization Schema Google Maps
Similar Organizations
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
VectivBio
VectivBio is a biotechnology company committed to making a difference in the lives of patients suffering from serious rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sanofi Ventures
Sanofi Ventures investment in Series B - Minervax
Wellington Partners
Wellington Partners investment in Series B - Minervax
LF Investment
LF Investment investment in Series B - Minervax
Repair Impact Fund
Repair Impact Fund investment in Series B - Minervax
Industrifonden
Industrifonden investment in Series B - Minervax
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Series B - Minervax
Adjuvant Capital
Adjuvant Capital investment in Series B - Minervax
Novo Holdings
Novo Holdings investment in Grant - Minervax
Repair Impact Fund
Repair Impact Fund investment in Grant - Minervax
Sunstone Life Science Ventures
Sunstone Life Science Ventures investment in Grant - Minervax
Official Site Inspections
http://www.minervax.com Semrush global rank: 6.13 M Semrush visits lastest month: 1.32 K
- Host name: linux213.curanet.dk
- IP address: 94.231.106.153
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
